Brønsted Acid-Catalyzed, Asymmetric Allenoate Claisen Reaction Authors: Rachael E. Hamilton, Ellen A. Berkley, Iain K. Laufer, Madeline E. Ruos, Brandon Smith, Anthony N. Dahi, Timothy J. Gallagher, Vanessa Justo, Flannery Warner, Anna G. Wenzel Published: 2024 ABSTRACT An auxiliary-based protocol is described for an asymmetric allenoate Claisen rearrangement. Silicated tosic acid (10 mol %) was used as an inexpensive, user-friendly catalyst. Stereochemical analysis revealed a preferential attack at the si face of prostereogenic olefin. The amine auxiliary was readily hydrolyzed and can be isolated from the reaction mixture (85–87% recovery). The resulting unsaturated β-keto esters were isolated in ≤99% yield and 98% ee. Diastereoselective examples provided a 96:4 syn:anti ratio of the resulting vicinal stereocenters. Since its discovery more than a century ago,1 the Claisen rearrangement has emerged as a versatile strategy for the rapid construction of organic structural complexity,2 with more than 15 variants reported.3 Of these, allenoate Claisen enables an efficient route to synthetically challenging, ε,ζ-unsaturated, β-keto ester derivatives. The seminal report of an allenoate Claisen reaction was by Lambert and MacMillan in 2002.4 Using zinc triflate as a Lewis acid catalyst, the authors elegantly described highly diastereoselective carbon–carbon bond formation due to the π-facial selectivity of the cumulene addition5 and a subsequent chairlike transition state,6 which is characteristic of many [3,3]-sigmatropic rearrangements. The products were isolated as the corresponding β-enamino esters [4 (Scheme 1)]. Hydrolysis product 5 was later observed when this system was further investigated by Pinho e Melo and co-workers.7 Allenoate Claisen Rearrangement In 2020, Sigman, Toste, and co-workers reported the development of doubly axial chiral phosphate (DAP) sodium salts for an enantioselective allenoate Claisen rearrangement.8 Computational investigations of this reaction’s enantioinduction mechanisms found the prostereogenic domain of 3 to be >5 Å from the Lewis acid catalyst, hindering the development of enantioselective variants, which commonly use proximal sterics to block one prochiral face to attack.9 The DAP catalyst that afforded the best results required an expanded chiral pocket constructed from two BINOL scaffolds appended with remote adamantyl moieties. Enantioselectivities of ≤95% ee and high diastereoselectivities were observed. To tackle the challenge of distal catalyst binding from the prostereogenic domain, we envisioned that an auxiliary approach might be able to achieve an asymmetric induction. Because chiral auxiliaries are stoichiometrically used, a drawback relative to using an asymmetric catalyst, they should ideally be inexpensive, readily installed, and cleaved upon completion of the reaction sequence, preferentially without racemization or epimerization. Auxiliary recyclability is also ideal for preserving the atom economy of the pericyclic reaction.10 We envisioned chiral pyrrolidines, which are commonly derived from the naturally occurring amino acid l-proline,11 would readily meet these criteria. Pyrrolidines are well-precedented to serve as proficient auxiliaries for asymmetric induction,12 and a report13 documenting aza-Claisen rearrangements using enantioenriched α-chiral allylamines indicated that this reaction would be amenable to chiral transfer. Our initial efforts sought to investigate allene 1a, a cumulene readily prepared from commercial starting materials, with chiral allyl amines using aluminum trichloride (10 mol %) as the reaction catalyst (Table 1). Unfortunately, proline-derived allyl amines 2a and 2b afforded negligible conversion of 1a via GC (<5%). Thinking that amine sterics might be hindering reaction conversion, we next investigated 2c, which has a smaller steric footprint. We were gratified to see the successful formation of 5, albeit with a modest yield (57%) and enantioselectivity (51% ee). Interestingly, despite the small size of its R group, amine 2c appears to provide optimal stereoinduction, as modification of the methyl ether in 2c to a phenyl ether (2d) afforded diminished reaction performance (40% yield, 44% ee). Table 1Investigation of Chiral Allyl Amines in the Allenoate Claisen Reaction of 1aaentryamineconversionb (%)yield of 5c (%)eed (%)12anegligible––22bnegligible––32c64605142d484544aConducted on a 0.29 mmol scale using a catalyst (10 mol %) in CH2Cl2 (0.2 M).bDetermined via GC relative to dodecane as an internal standard.cIsolated yield.dDetermined by chiral HPLC. Investigation of Chiral Allyl Amines in the Allenoate Claisen Reaction of 1aa Conducted on a 0.29 mmol scale using a catalyst (10 mol %) in CH2Cl2 (0.2 M). Determined via GC relative to dodecane as an internal standard. Isolated yield. Determined by chiral HPLC. The catalyst and solvent were varied to optimize our lead result (Table 2). After confirming the absence of an uncatalyzed reaction (entry 1), we next investigated Zn(OTf)2, the catalyst employed in the report by Lambert and MacMillan. Only slight increases in yield and enantioselectivity were observed relative to those of aluminum trichloride. In contrast, switching to the use of Brønsted acid catalysts afforded significantly better results (entries 4–6). While the yield was somewhat diminished when trifluoroacetic acid (10 mol %) was employed as the reaction catalyst (52% yield, entry 4), we were gratified to see a significant increase in enantioselectivity to 83% ee. Switching to p-toluenesulfonic acid (TsOH) as the reaction catalyst improved overall reaction performance [82% yield and 88% ee (entry 5)]. On the basis of this result, we opted to investigate the use of silicated tosic acid (Si-TsOH, 0.65 mmol/g), a common proton scavenger14 with previously described catalytic potential.15 The use of Si-TsOH afforded the best product yield (92%) and enantioselectivity (91% ee). The superior performance of Brønsted acids over Lewis acids is not surprising, as they have been shown to better facilitate catalyst turnover and the formation of the rigid transition states required for a high degree of stereocontrol in pericyclic reactions.16 Table 2Optimization of the Allenoate Claisen Reactionaentrycatalystsolventyield (%)eeb (%)1–CH2Cl2––2AlCl3CH2Cl260513Zn(OTf)2CH2Cl268534CF3COOHCH2Cl252835TsOHCH2Cl282886Si-TsOHCH2Cl292917Si-TsOHtoluene13828Si-TsOHTHF33609Si-TsOHEtOAc418810Si-TsOHCH3CN965111Si-TsOHCH3NO2988812Si-TsOH1:1 CH2Cl2/CH3NO29892aConducted on a 0.29 mmol scale using a catalyst (10 mol %) in a solvent (0.2 M).bDetermined by chiral HPLC. Optimization of the Allenoate Claisen Reactiona Conducted on a 0.29 mmol scale using a catalyst (10 mol %) in a solvent (0.2 M). Determined by chiral HPLC. We found the allenoate Claisen reaction to be highly sensitive to the reaction solvent (Table 2, entries 7–12), where a complicated interplay of effects on product yields and enantioselectivities was observed. We were particularly intrigued by the result when nitromethane (CH3NO2) was used as the reaction solvent (98% yield and 88% ee). While the enantioselectivity was diminished relative to that observed in CH2Cl2 (entry 11 vs entry 6), CH3NO2 consistently afforded nearly quantitative yields within a 24 h time period. We found a 50:50 CH2Cl2/CH3NO2 mixed solvent system to convey the best properties of its constituents (98% yield and 92% ee). Table 3 depicts the scope of the allenoate Claisen reaction. While the ethyl ester in 6 was derived from a commercially available allene, diminished enantioselectivity (82% ee) was observed relative to that of benzyl ester product 5 (92% ee). For this reason, we opted to focus our attention on allenes derived from benzyl esters. The use of allyl amines derived from trans-but-2-en-1-ol and trans-2-hexen-1-ol afforded 7 and 8, respectively, in high yields (98–99%) and enantioselectivities (98% ee). Product 9 (87% yield and 94% ee) highlights that 2-methyl substitution on the allyl amine was well-tolerated. In cases in which vicinal stereocenters were formed (10 and 11), high diastereoselectivities (96:4 syn:anti) were observed. Interestingly, despite the requisite allenes for 10 and 11 being axially chiral, moderate enantioselectivities were still obtained (86% and 74% ee, respectively). Previous studies have observed a dynamic kinetic asymmetric transformation (DyKAT) pathway in the reaction of amines with allenes.9,17 In this, the nucleophilic addition of the amine destroys the preexisting chiral axis of the cumulated diene to provide a common intermediate that then proceeds to undergo a [3,3]-rearrangement as the rate-determining step. A preference for the syn adduct was established by nuclear magnetic resonance (NMR), where the Jα,β values fell within the range of 6–9 Hz anticipated for this stereochemical configuration.4,18 Product stereochemistry was determined by correlating the optical rotation of 6 to a literature value.8,19Figure 1 depicts the proposed transition state model in which the auxiliary promotes preferential attack at the si face of the prochiral olefin. Table 3Scope of the Allenoate Claisen Reaction Scope of the Allenoate Claisen Reaction Proposed stereochemical model for the allenoate Claisen reaction. Reactions to form 5 and 10 have been scaled to 1 mmol, with no diminishment in reaction yields or stereoselectivities. Ambient conditions were readily tolerated; no rigorous exclusion of air or water was required. To boost the atom economy of this transformation, the chiral amine auxiliary, (S)-(+)-2-(methoxymethyl)pyrrolidine, was demonstrated to be readily isolable from the reaction mixture using simple acid–base extraction techniques (85–87% recovery). The silicated TsOH reaction catalyst could be recycled with limitations. When investigated in the reaction to form 5 on a 1 mmol scale under the optimized conditions, enantioselectivity was largely retained [92% ee to 91% ee over the course of being recycled twice (Table 4)]. However, the product yield was observed to decrease with each recycling. Similar diminishment has been reported with other silicated Brønsted acid systems.20 CHNS/O elemental analysis of the recycled catalyst from these systems found a diminishment of the catalyst loadings present. Table 4Catalyst Recycling Experimentsaentryyield of 5 (%)eeb (%)initial9692recycle 18791recycle 28191aConducted on a 1.0 mmol scale using Si-TsOH (10 mol %) in a 1:1 CH2Cl2/CH3NO2 mixed catalyst system (0.2 M).bDetermined by chiral HPLC. Catalyst Recycling Experimentsa Conducted on a 1.0 mmol scale using Si-TsOH (10 mol %) in a 1:1 CH2Cl2/CH3NO2 mixed catalyst system (0.2 M). Determined by chiral HPLC. The greatest challenge to this methodology remains a poor tolerance to steric substitution on the allene. For example, products 9–11, derived from the R1 = methyl-substituted allene, required a reaction time of 48 h. Increasing the steric bulk on the allene (R1) from methyl to phenyl or isopropyl led to minimal product formation after 48 h. A user-friendly protocol for an asymmetric allenoate Claisen rearrangement has been described to access ε,ζ-unsaturated β-keto ester derivatives with high enantio- and diastereocontrol. The ease of reaction setup and demonstrated auxiliary recovery provide facile access to this useful product class.20,2f We are currently applying principles from this system toward catalytic methodologies that employ tandem amine and Brønsted acid activation. Experimental Section General Information (S)-(+)-2-(Methoxymethyl)pyrrolidine was purchased from Combi-blocks. Ethyl buta-2,3-dienoate was purchased from aablocks. SiliaBond tosic acid (silicated tosic acid, 0.65 mmol/g) was obtained from Silicycle. (2E)-But-2-en-1-ol was purchased from Enamine. All other compounds were purchased from Sigma-Aldrich, Alfa Aesar, Boc Sciences, TCI America, Strem, and Thermo Fisher Scientific. NMR solvents were purchased from Cambridge Isotope Laboratories, Inc. Flash chromatography of compounds was performed utilizing silica gel 60 (32–63 μm) purchased from Bodman Industries or either SNAP Ultra or Sfär silica columns purchased from Biotage using a Biotage Isolera One chromatography device. NMR spectra were recorded on a Bruker 400 MHz or Bruker AVANCETM III 500 US+ NMR spectrometer. Chemical shifts for protons are reported in parts per million downfield from tetramethylsilane and are referenced to residual protium in the NMR solvent (CHCl3, δ 7.26; CH2Cl2, δ 5.32). Chemical shifts for carbon are reported in parts per million downfield from tetramethylsilane and were referenced to the carbon resonances of the solvent (CHCl3, δ 77.23; CH2Cl2, δ 53.84). Data are represented as follows: chemical shift, integration, multiplicity (s, singlet; d, doublet; q, quartet; p, quintet; sx, sextet; sep, septet; dq, doublet of quartets; m, multiplet; br, broad), coupling constants in hertz, and assignment. Note that Claisen products were typically observed via NMR to have 0–18% of the enol tautomer present; in some repetitions of these experiments, the enol tautomer was not observed. IR spectroscopy was performed using a Thermo Fisher Nicolet iS20 FTIR instrument. Gas chromatography (GC) data were acquired on an RTX-5 column (length of 15 m, inside diameter of 0.25 mm, df of 0.10 μm) using a Shimadzu GC-2010 instrument. GC data were acquired according to the following method: 50 °C for 3 min, followed by heating at a rate of 15 °C/min for 12 min, followed by an isothermal hold at 230 °C for 2 min (17 min total). A Shimadzu 10ADvp HPLC system was used for enantiomeric analysis. Polarimetry was performed by using a Jasco P-2000 polarimeter. Accurate mass spectrometric data were obtained via UPLC-MS using a Waters ACQUITY UPLC H-Class PLUS System connected to a Waters Xevo G2-XS QTof instrument. Caution!Nitromethane is a flammable, reactive, and explosive substance that can be hazardous to your health. All sources of ignition should be removed before use. Nitromethane can be desensitized via the addition of dichloromethane (1:1).(21)Exposure to dichloromethane can lead to an increased risk of developing cancer, adverse effects on the heart, central nervous system, and liver, and skin or eye irritation. Use only in a well-ventilated area, preferably in a fume hood.22 General Protocol for the Allenoate Claisen Reaction A 1:1 dichloromethane/nitromethane mixture (1.5 mL) was added to a 4 mL vial with a small stir bar. The allyl amine (0.44 mmol, 1.5 equiv) and allene (0.29 mmol, 1.0 equiv) were sequentially added, and the reaction mixture was allowed to stir for 20 s. Silicated tosic acid (0.65 mmol/g, 45 mg, 0.029 mmol, 0.10 equiv) was then added. The reaction mixture was allowed to stir under ambient conditions. At 24 h, the reaction mixture was filtered using dichloromethane to remove the silica catalyst; the silica was rinsed with 2 × 0.5 mL portions of dichloromethane. Next, 1.5 mL of 1 N aqueous HCl was added to the filtrate. The mixture was stirred for 6 h to hydrolyze the product, which was then extracted from the aqueous layer using dichloromethane (3 × 2 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated. The product was purified via flash chromatography on silica gel. Benzyl (S)-3-Oxo-5-phenylhept-6-enoate (5) The title compound was isolated as a colorless oil (88 mg, 98% yield): TLC 15% ethyl acetate in hexanes, Rf = 0.38, UV and KMnO4 visualization; IR (thin film, cm–1) 1744 (s), 1717 (s), 1638 (m), 1265 (s), 1225 (s); 1H NMR [500 MHz, CDCl3, 20 °C; 10% benzyl (S)-3-oxo-5-phenylhept-6-enoate enol tautomer peaks present and peaks designated with an asterisk] δ 12.09* (1H, s, OH), 7.46–7.25 (10H, m, ArH), 6.02 (1H, m, =CH), 5.23 (2H, s, CH2Ph), 5.18–5.04 (2H, m, =CH), 4.01 (1H, m, CHPh), 3.87* (1H, m, CHPh), 3.50 (2H, m, COCH2CO), 3.10–2.98 (2H, m, CH2CHPh) 2.70* (2H, m, CH2CHPh); 13C{1H} NMR [125 MHz, CDCl3, 20 °C; benzyl (S)-3-oxo-5-phenylhept-6-enoate enol tautomer peaks present and peaks designated with an asterisk] δ 200.9, 176.7*, 172.5*, 167.0, 142.8*, 142.6, 140.4*, 140.3, 135.4, 128.9, 128.8, 128.78*, 128.7, 128.6, 128.3*, 127.8, 127.7*, 126.9, 126.85*, 115.4*, 115.2, 90.8*, 67.4, 65.9*, 50.1, 48.4, 46.4*, 44.4, 41.4*; [α]D22.3 = −15.8° (c = 0.025 g/cm3, CHCl3); HRMS (ESI-TOF) m/z [M + H]+ calcd for C20H21O3 309.1491, found 309.1476, found 309.1476; HPLC (Chiralcel OD, 1% isopropanol/hexanes, 1.0 mL/min, λ = 254 nm) tR (major) = 11.5 min, tR (minor) = 12.7 min, 92% ee. Ethyl (S)-3-Oxo-5-phenylhept-6-enoate (6) The title compound was isolated as a colorless oil (71 mg, 99% yield): TLC 15% ethyl acetate in hexanes, Rf = 0.43, UV and KMnO4 visualization; IR (thin film, cm–1) 2982 (w), 1740 (s), 1715 (s), 1638 (w), 1238 (m), 1030 (m), 909 (s), 730 (s), 701 (s); 1H NMR [500 MHz, CDCl3, 20 °C; 10% ethyl (S)-3-oxo-5-phenylhept-6-enoate enol tautomer peaks present and peaks designated with an asterisk] δ 12.09* (1H, s, OH), 7.32–7.29 (2H, m, ArH), 7.23–7.19 (3H, m, ArH), 6.01–5.92 (1H, m, CH2=CH), 5.09–5.01 (2H, m, CH2=CH), 4.89* (1H, s, =CH), 4.15 (2H, q, J = 7.1 Hz, OCH2CH3), 3.93 (1H, q, J = 7.0 Hz, CHPh), 3.81–3.74* (2H, q, J = 7.6 Hz, OCH2CH3), 3.35 (2H, d, J = 2.8 Hz, CH2), 2.99 (2H, qd, J1 = 16.9 Hz, J2 = 6.9 Hz, CH2), 2.61–2.58* (2H, m, CH2), 1.25 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR [125 MHz, CDCl3, 20 °C; ethyl (S)-3-oxo-5-phenylhept-6-enoate enol tautomer peaks present and peaks designated with an asterisk] δ 201.1, 176.2*, 167.2, 143.1*, 142.7, 140.5*, 140.4*, 128.9, 128.8*, 127.8, 127.7*, 126.9, 126.8*, 115.3*, 115.1, 91.0*, 61.6, 60.2*, 50.1, 48.4, 46.4*, 44.4, 41.3*, 14.4*, 14.3; [α]D22.8 = −39.5° (c = 0.040 g/cm3, CHCl3); HRMS (ESI-TOF) m/z [M + H]+ calcd for C15H19O3 247.1334, found 247.1315; HPLC (Chiralcel OD, 0.25% isopropyl alcohol/hexanes, 1.0 mL/min, λ = 220 nm) tR (major) = 8.2 min, tR (minor) = 9.1 min, 81% ee. Benzyl (S)-5-Methyl-3-oxohept-6-enoate (7) The title compound was isolated as a colorless oil (70 mg, 98% yield): TLC 15% ethyl acetate in hexanes, Rf = 0.40, UV–vis and KMnO4 visualization; IR (thin film, cm–1) 2964 (m), 1740 (s), 1713 (s), 1222 (m), 1150 (m); 1H NMR [500 MHz, CDCl3, 20 °C; 15% benzyl (S)-5-methyl-3-oxohept-6-enoate enol tautomer peaks present and peaks designated with an asterisk] δ 12.01* (1H, s, OH), 7.38–7.32 (5H, m, PhH), 5.76–5.69 (1H, m, CH=), 5.17 (2H, s, CH2Ph), 5.01–4.93 (2H, m, CH=), 3.47 (2H, s, CH2), 2.75–2.69 (1H, m, CH), 2.67 (2H, qd, J1 = 6.9 Hz, J2 = 16.3 Hz, CH2), 2.19* (2H, dq, J1 = 14.1 Hz, J2 = 7.0 Hz, CH2), 1.04* (3H, d, J = 6.5 Hz, CH3), 1.00 (3H, d, J = 6.6 Hz, CH3); 13C{1H} NMR [125 MHz, CDCl3, 20 °C; benzyl (S)-5-methyl-3-oxohept-6-enoate enol tautomer peaks present and peaks designated with an asterisk] δ 201.7, 177.7*, 172.6*, 167.1, 142.9*, 142.5, 136.1*, 135.5, 128.82, 128.79*, 128.7, 128.6, 128.5*, 128.4*, 113.7, 90.4*, 67.3, 65.9*, 49.9, 49.7, 42.4*, 35.2*, 33.2, 19.9; [α]D22.5 = −8.1° (c = 0.027 g/cm3, CHCl3); HRMS (ESI-TOF) m/z [M + H]+ calcd for C15H19O3 247.1334, found 247.1354; HPLC (Chiralcel OD, 0.25% IPA in hexanes, 0.5 mL/min, λ = 254 nm) tR (major) = 18.1 min, tR (minor) = 18.6 min, 98% ee. Benzyl (S)-3-Oxo-5-vinyloctanoate (8) The title compound was isolated as a colorless oil (78 mg, 99% yield): TLC 15% ethyl acetate in hexanes, Rf = 0.41, UV–vis and KMnO4 visualization; IR (thin film, cm–1) 2957 (m), 2928 (m), 1742 (s), 1720 (s), 1631 (m), 1384 (m), 1263 (m), 1148 (m); 1H NMR [500 MHz, CDCl3, 20 °C; 2% benzyl (S)-3-oxo-5-vinyloctanoate enol tautomer peaks present and peaks designated with an asterisk] δ 12.00* (1H, s, OH), 7.36–7.33 (5H, m, ArH), 5.63–5.46 (1H, m, CH=), 5.17 (2H, s, CH2Ph), 5.11–4.96 (2H, m, CH=), 3.49–3.45 (1H, m, CH), 2.81 (1H, qd, J1 = 9.4 Hz, J2 = 3.0 Hz, CH), 2.58–2.48* (3H, m, CH, CH2), 2.19 (1H, s, CH), 2.13 (1H, s, CH), 1.37–1.16 (4H, m, CH2CH2), 0.86–0.82 (3H, m, CH3); 13C{1H} NMR [125 MHz, CDCl3, 20 °C; benzyl (S)-3-oxo-5-vinyloctanoate enol tautomer peaks present and peaks designated with an asterisk] δ 202.6, 177.9*, 172.5*, 168.8, 138.2, 135.5, 128.8, 128.6, 128.5, 128.4*, 117.7, 90.4*, 67.2, 65.9*, 65.3, 44.1, 34.7, 29.6, 20.2, 13.9; [α]D22.1 = −15.8° (c = 0.016 g/cm3, CHCl3); HRMS (ESI-TOF) m/z [M + H]+ calcd for C17H23O3 275.1647, found 275.1645; HPLC (0.5% isopropanol/hexanes, 1.0 mL/min, λ = 254 nm) tR (major) = 6.5 min, tR (minor) = 7.0 min, 98% ee. Benzyl (S)-5,6-Dimethyl-3-oxohept-6-enoate (9) The reaction was allowed to proceed for 48 h. The product was isolated as a colorless oil (66 mg, 87% yield): TLC 15% ethyl acetate in hexanes, Rf = 0.41, UV–vis and KMnO4 visualization; IR (thin film, cm–1) 2972 (m), 2934 (m), 1455 (m), 1739 (s), 1711 (s), 1647 (w), 1152 (s), 697 (s); 1H NMR [500 MHz, CDCl3, 20 °C; 8% benzyl (S)-3-hydroxy-5,6-dimethylhepta-2,6-dienoate enol tautomer present and peaks designated with an asterisk] δ 12.05* (1H, s, OH), 7.38–7.33 (5H, m, ArH), 5.18 (2H, s, CH2Ph), 5.05* (2H, s, CH2Ph), 4.78 (1H, s, CH=), 4.71* (1H, s, CH=), 4.68 (1H, s, CH=), 3.54 (2H, s, COCH2CO2Bn), 2.82 (1H, sx, J = 6.8 Hz, CHCH3), 2.46* (1H, dd, J1 = 14.1 Hz, J2 = 7.1 Hz, CH2CO), 2.39 (1H, dd, J1 = 13.7 Hz, J2 = 6.5 Hz, CH2CO), 2.06* (1H, dd, J1 = 13.7 Hz, J2 = 7.7 Hz, CH2CO), 2.01 (1H, dd, J1 = 14.2 Hz, J2 = 8.1 Hz, CH2CO), 1.70* (3H, s, =CHCH3), 1.68 (3H, s, =CHCH3), 1.11 (3H, d, J = 6.8 Hz, CH3CH), 1.08 (3H, d, J = 6.9 Hz, CH3CH); 13C{1H} NMR [125 MHz, CDCl3, 20 °C; (S)-3-hydroxy-5,6-dimethylhepta-2,6-dienoate enol tautomer present and peaks designated with an asterisk] δ 201.7, 177.7*, 172.6*, 167.1, 142.9*, 142.5, 136.1*, 135.5, 128.82, 128.79*, 128.7, 128.6, 128.5*, 128.3*, 113.7, 90.4*, 67.3, 65.9*, 49.9, 49.7, 42.4*, 35.2*, 33.2, 19.9, 19.7*; [α]D22.2 = −9.6° (c = 0.030 g/cm3, CHCl3); HRMS (ESI-TOF) m/z [M + H]+ calcd for C16H21O3 261.1491, found 261.1468; HPLC (Chiralcel OD, 0.25% isopropanol/hexanes, 1.0 mL/min, λ = 254 nm) tR (major) = 15.8 min, tR (minor) = 16.3 min, 94% ee. Benzyl (4S,5R)-4,5-Dimethyl-3-oxohept-6-enoate (10) The reaction was allowed to proceed for 48 h. The product was isolated as a colorless oil (48 mg, 63% yield): TLC 15% ethyl acetate in hexanes, Rf = 0.53, UV–vis and KMnO4 visualization; IR (thin film, cm–1) 2972 (w), 1741 (s), 1711 (s), 1640 (m), 1455 (m), 1218 (s), 1148 (s); 1H NMR [500 MHz, CDCl3, 20 °C; 18% benzyl (S)-3-hydroxy-5,6-dimethylhepta-2,6-dienoate enol tautomer peaks present and peaks designated with an asterisk; 96:4 syn:anti ratio observed and anti peaks designated with a dagger] 12.06* (1H, s, OH), 7.38–7.33 (5H, m, ArH), 5.78–5.68 (1H, m, CH=), 5.65–5.55† (1H, m, CH=), 5.17 (2H, s, CH2Ph), 5.02–4.98 (2H, m, CH=), 3.51 (2H, s, COCH2CO), 3.27† (2H, s, COCH2CO), 2.61 (1H, p, J = 6.8 Hz, CHMe), 2.52–2.47 (1H, m, CHMe), 2.22–2.20* (1H, m, CHMe), 1.84–1.83* (1H, m, CHMe), 1.08* (3H, d, J = 6.8 Hz, CH3), 1.05 (3H, d, J = 6.8 Hz, CH3), 1.00* (3H, d, J = 6.8 Hz, CH3), 0.97 (3H, d, J = 6.8 Hz, CH3); 13C{1H} NMR [125 MHz, CDCl3; benzyl (S)-3-hydroxy-5,6-dimethylhepta-2,6-dienoate enol tautomer peaks present and peaks designated with an asterisk] δ 205.8, 182.1*, 172.8*, 167.2, 142.0*, 136.1*, 141.5, 135.6, 128.8, 128.6, 128.5, 128.47*, 128.41*, 115.0, 114.3*, 89.1*, 67.2, 65.9*, 51.6, 48.9, 44.7*, 40.5*, 39.6, 16.3*, 15.9, 14.3*, 12.6; [α]D22.2 = −8.9° (c = 0.024 g/cm3, CHCl3); HRMS (ESI-TOF) m/z [M + H]+ calcd for C16H21O3 261.1491; HPLC (Chiralpak 1A, 0.35% isopropanol/hexanes, 1.0 mL/min, λ = 254 nm) tR (major) = 5.8 min, tR (minor) = 6.2 min, 86% ee. Benzyl (4S,5R)-4-Methyl-3-oxo-5-phenylhept-6-enoate (11) The reaction was allowed to proceed for 48 h. The product was isolated as a colorless oil (62 mg, 66% yield): TLC 15% ethyl acetate in hexanes, Rf = 0.35, UV–vis and KMnO4 visualization; IR (thin film, cm–1) 2931 (m), 1741 (s), 1713 (s), 1638 (m), 1493 (m), 1227 (m), 1157 (m); 1H NMR [500 MHz, CDCl3, 20 °C; 11% benzyl (4S,5R)-4-methyl-3-oxo-5-phenylhept-6-enoate enol tautomer peaks present and peaks designated with an asterisk; 25:1 syn:anti ratio observed and anti peaks designated with a dagger] δ 12.08* (1H, s, OH), 11.90† (1H, s, OH), 7.39–7.14 (10H, m, ArH), 6.01–5.87 (1H, m, CH=), 5.19 (2H, s, CH2Ph), 5.09* (2H, s, CH2Ph), 5.01 (1H, d, J = 16.1 Hz, CH=), 5.00 (1H, d, J = 11.5 Hz, CH=), 3.53 (2H, s, COCH2CO), 3.47 (1H, t, J = 9.3 Hz, CHPh), 3.41–3.38† (1H, m, CHPh), 3.09 (1H, dq, J1 = 11.9 Hz, J2 = 7.0 Hz, CHCH3), 3.00–2.93† (1H, m, CHCH3), 2.52–2.59* (1H, m, CHCH3), 1.15† (3H, d, J = 6.8 Hz, CH3), 0.97* (3H, d, J = 6.8 Hz, CH3), 0.89 (3H, d, J = 6.9 Hz, CH3); 13C{1H} NMR (125 MHz, CDCl3, 20 °C) δ 205.9, 167.0, 141.3, 135.6, 129.0, 128.8, 128.7, 128.6, 128.2 127.1, 116.6, 67.3, 53.3, 51.4, 49.8, 15.7; [α]D22.2 = −8.7° (c = 0.030 g/cm3, CHCl3); HRMS (EI) calcd for C21H23O3 [M+] 323.1647, found 323.1639; HPLC (Chiralpak AS, 2.0% isopropanol/hexanes, 1.0 mL/min, λ = 220 nm) tR (major) = 10.3 min, tR (minor) = 11.1 min, 77% ee.